Inspired by this post I have six points for discussion. Choose one of them and start discussing.
High probability of success - significance of the historic trials in terms of probability of success of Pillars 2 and 3 ( Breast Cancer and AML trials )
The baseline value of Pillars 2 and 3 to Big Pharma (in the context of probability shown by #1)
The potential stratospheric value of Pillar 1 to Big Pharma (lots of great info has been shared by @Mason14 in this post)
That Big Pharma initiate most buyout transactions during Preclinical, Phase 1 or 2
That RACE is significantly undervalued to peers in the US
The effort that management are putting into getting this right
RAC Price at posting:
$3.73 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)